New cyclodextrin bioconjugates for active tumour targeting. - Wikidata - awgldk - TriplyDB

New cyclodextrin bioconjugates for active tumour targeting.

New cyclodextrin bioconjugates for active tumour targeting.

http://www.wikidata.org/entity/Q40110851

about

Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.Advanced drug delivery systems of curcumin for cancer chemoprevention Recent advances and future directions in amphiphilic cyclodextrin nanoparticles.The targets of curcumin.Recent trends in oral transmucosal drug delivery systems: an emphasis on the soft palatal route.Advances in nanotechnology-based delivery systems for curcumin.Recent advances in cyclodextrin delivery techniques.Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs.Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers.Development of chitosan/poly-γ-glutamic acid/pluronic/curcumin nanoparticles in chitosan dressings for wound regeneration.Monovinyl sulfone β-cyclodextrin. A flexible drug carrier system.

P2860

Q24614491-85FB82C8-267F-41D8-96A8-331A1369AC53 Q33500696-000FA14F-4048-48D3-8B7C-09428426DDAD Q34071871-9DF95D00-4277-4BE4-9C4F-318B170347E6 Q35150975-BD28BF88-CC8E-4F9F-94E7-8B9F7D2F13CA Q37586465-D852B5F0-A836-4050-AE4B-65691AF8BFCE Q37800949-D040E8E9-775F-4AD8-94A4-57EE8F8E8343 Q38003426-E3F038E8-3713-48C5-94D6-F1653DA20BCC Q38030643-79D9369D-DC84-48CF-9E59-469C2E562300 Q38534300-A7243165-E921-4EEC-B9A6-8C35C9BBC35E Q39145487-2C5B3040-DB61-4891-B029-A86FE9BE4409 Q39661923-03A0242F-8DDD-4A7B-B551-E2B5639B157B Q40971052-1AA7EBF8-A41C-43AE-9515-BACAC5E285AA Q46793465-6320AC58-2D4E-4C3B-A5C4-7D2631F6822E

P2860

New cyclodextrin bioconjugates for active tumour targeting.

http://www.wikidata.org/entity/Q40110851

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

New cyclodextrin bioconjugates for active tumour targeting.

@en

type

label

New cyclodextrin bioconjugates for active tumour targeting.

@en

prefLabel

New cyclodextrin bioconjugates for active tumour targeting.

@en

P1433

Q40110851-07F74A4A-E52F-4C4A-BAF0-52FB3CC20C79

P1476

Q40110851-503F6CE4-2850-4F7E-B616-83CE3BAFCB10

P2093

Q40110851-4CBFB72D-3791-4A6B-8C51-116C67991FB7

Q40110851-CBA25723-07BF-41A1-A668-10DCD6CD78BF

Q40110851-D01A788E-D8B3-461D-B52B-55AB374D6B4D

P2860

Q40110851-09487C24-F2D1-4B53-907F-28D02C2896BC

Q40110851-09DCF991-F282-4C41-A4B3-9A3355D8E5E5

Q40110851-1688D051-34A1-4346-BAB2-8444837653A8

Q40110851-178C5AE6-88FB-45AE-B82C-8E9B79935B95

Q40110851-23CBEA9A-14B9-44A9-9920-A2235F863871

Q40110851-3487637B-2D28-481F-9CA8-BE19DB10A1B7

Q40110851-3ADD2C69-656C-492A-86FB-C94F4FCBCDED

Q40110851-3BF27C3C-B236-4A7C-9D0F-1AA106DC46A4

Q40110851-4242E609-23BE-4344-948E-D827FCB58823

Q40110851-43F14440-A00C-4747-A0D1-E49D3CB2CEB4

P304

Q40110851-D71A250A-03D1-4003-937F-EA7705B404B9

P31

Q40110851-437BA805-1E76-4974-92B3-3E938964A9DA

P356

Q40110851-1F494AFC-FA9B-4824-AFD7-B25263964138

P433

Q40110851-11729650-75FC-456E-842B-9132BEC0D82D

P478

Q40110851-0625E02D-68FC-41B6-8A09-61FBC8E54023

P50

Q40110851-6BBA3717-4C11-4046-9172-E196E0B56BF3

P577

Q40110851-70AA3F19-91E1-4E53-AD03-68FF27EB7742

P698

Q40110851-4AD73E1B-C20B-40FD-856C-12C5A632F93C

P356

10611860701349752

P1433

Journal of Drug Targeting

P1476

New cyclodextrin bioconjugates for active tumour targeting

@en

P2093

Alessandra Semenzato

http://www.w3.org/2001/XMLSchema#string

Paolo Caliceti

http://www.w3.org/2001/XMLSchema#string

Sara Bersani

http://www.w3.org/2001/XMLSchema#string

P2860

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

How curcumin works preferentially with water soluble antioxidants.

Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.

Bioconjugation in pharmaceutical chemistry.

Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.

Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Folate-mediated targeting: from diagnostics to drug and gene delivery.

Solid lipid nanoparticles: production, characterization and applications.

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications.

Stability of curcumin in buffer solutions and characterization of its degradation products.

P304

379-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10611860701349752

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Salmaso

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17613656

http://www.w3.org/2001/XMLSchema#string